AP4 is a mediator of epithelial-mesenchymal transition and metastasis in colorectal cancer
about
Role of microRNA in epithelial to mesenchymal transition and metastasis and clinical perspectives.The YAP1/SIX2 axis is required for DDX3-mediated tumor aggressiveness and cetuximab resistance in KRAS-wild-type colorectal cancer.USP22 drives colorectal cancer invasion and metastasis via epithelial-mesenchymal transition by activating AP4.Pan-cancer EMT-signature identifies RBM47 down-regulation during colorectal cancer progression.A novel TetR-regulating peptide turns off rtTA-mediated activation of gene expressionAn axis involving SNAI1, microRNA-128 and SP1 modulates glioma progression.Integrating transcriptional and protein interaction networks to prioritize condition-specific master regulators.p53-Regulated Networks of Protein, mRNA, miRNA, and lncRNA Expression Revealed by Integrated Pulsed Stable Isotope Labeling With Amino Acids in Cell Culture (pSILAC) and Next Generation Sequencing (NGS) AnalysesPopulation Heterogeneity in the Epithelial to Mesenchymal Transition Is Controlled by NFAT and Phosphorylated Sp1.The histone variant H2A.X is a regulator of the epithelial-mesenchymal transitionDDX3 promotes tumor invasion in colorectal cancer via the CK1ε/Dvl2 axis.Silencing of AP-4 inhibits proliferation, induces cell cycle arrest and promotes apoptosis in human lung cancer cellsOsteopontin promotes epithelial-mesenchymal transition of hepatocellular carcinoma through regulating vimentinDDX3 enhances oncogenic KRAS‑induced tumor invasion in colorectal cancer via the β‑catenin/ZEB1 axis.p53 down-regulates SARS coronavirus replication and is targeted by the SARS-unique domain and PLpro via E3 ubiquitin ligase RCHY1SNAIL and miR-34a feed-forward regulation of ZNF281/ZBP99 promotes epithelial-mesenchymal transition.Comparative genetic screens in human cells reveal new regulatory mechanisms in WNT signaling.IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis.MYCN promotes neuroblastoma malignancy by establishing a regulatory circuit with transcription factor AP4.The p53/microRNA connection in gastrointestinal cancer.Proteasome-dependent degradation of transcription factor activating enhancer-binding protein 4 (TFAP4) controls mitotic division.Alternative splicing of DNA damage response genes and gastrointestinal cancers.Meta-analysis of gene expression profiles identifies differential biomarkers for hepatocellular carcinoma and cholangiocarcinoma.Gene set enrichment analysis of the NF-κB/Snail/YY1/RKIP circuitry in multiple myeloma.Modulation of transcription factor binding and epigenetic regulation of the MLH1 CpG island and shore by polymorphism rs1800734 in colorectal cancer.p53 directly activates cystatin D/CST5 to mediate mesenchymal-epithelial transition: a possible link to tumor suppression by vitamin D3AP4 activates cell migration and EMT mediated by p53 in MDA-MB-231 breast carcinoma cells.Interplay Between Transcription Factors and MicroRNAs Regulating Epithelial-Mesenchymal Transitions in Colorectal Cancer.Myeloid zinc-finger 1 (MZF-1) suppresses prostate tumor growth through enforcing ferroportin-conducted iron egress.AP4 is required for mitogen- and c-MYC-induced cell cycle progression.Induction of integrin α2 in a highly bone metastatic human prostate cancer cell line: roles of RANKL and AR under three-dimensional suspension culture.Molecular mechanism of activating protein-4 regulated growth of hepatocellular carcinoma.Down-regulated miR-15a mediates the epithelial-mesenchymal transition in renal tubular epithelial cells promoted by high glucose.Suppressor of cytokine signaling 1 modulates invasion and metastatic potential of colorectal cancer cells.Lgr5 expression, cancer stem cells and pancreatic cancer: results from biological and computational analyses.Repression of c-Kit by p53 is mediated by miR-34 and is associated with reduced chemoresistance, migration and stemness.Regulatory miRNAs in Colorectal Carcinogenesis and Metastasis.Expression of Activating Protein 4 and Its Relationships with Prognosis in Gastric Cancer.Regulation of activating protein-4-associated metastases of non-small cell lung cancer cells by miR-144.Overexpression of transcription factor activating enhancer binding protein 4 (TFAP4) predicts poor prognosis for colorectal cancer patients.
P2860
Q33559304-E8944476-DEB5-4740-9236-A84B76BC3D5CQ33588163-D27AFC37-0977-41D6-8E72-337A111F7E46Q33779205-91310771-59E4-4E48-9348-D94EE2658DDCQ33875488-F71EFDE5-2DF2-4EF8-A4AB-291F3D9388D7Q35165468-A6D0074B-F481-49C4-A6DA-7E160A83F98CQ35193962-6D930253-62A3-4A07-B390-9AE1422F9E9DQ35843914-1B1E5DAD-0E6D-41D9-9FEA-C8ABDA2C3859Q36133972-865A01AB-9782-401D-94C9-3FFCE6DCF735Q36233870-8FA06D2D-6E71-4077-A9A2-721CBFD750C3Q36587539-7E4CE4C2-8FB2-46E0-9C06-D169770528EBQ36595592-D503F84B-0772-43D0-BB7F-C10A2267DE3CQ36954636-D74E1051-2AF3-4785-967C-3CCE6B0E3D37Q37022356-B50F3EBF-5513-4FBB-9485-8FC8DC7995B5Q37225645-75A3498A-AC0C-4F5E-82B7-E46A26CD47A7Q37258617-40591254-D8EC-4645-BAC3-3695EE521A21Q37352692-A96C121D-9BFD-47AD-A25D-8AD6535D7972Q37600803-126225D1-FD9C-4BB2-B1A0-18BD09DDB6E8Q37679965-7A801427-1E00-472A-93A2-658258D67373Q37688166-088748FC-DC49-4CB6-9391-61DF1E11A165Q38261312-2A3C9C7B-96D6-44C8-9C52-8778EDE4E37AQ38268314-91F89689-296D-4087-BDDF-62BAB6C83A23Q38291477-7111D155-5ED0-4694-B4BB-7FAB2C98651BQ38441297-60192BDB-8BDF-4A02-BB6C-5FE24660567BQ38480261-48976897-88F8-40F7-A8D1-76F965B28894Q38711869-28F3D4AC-A096-4B78-8461-65185C73150CQ38855132-CF156EFF-B323-44C3-8BA6-53D7063E5A6DQ38868164-789F1E92-B2E8-4849-88A2-7B0ED4A836E4Q38940594-ECEA4BF6-EA6F-4AC0-90CC-8A58FF966484Q38950381-E297F180-CF45-4A98-AF19-5FCC0522560CQ38952887-FBFE4EF5-DC85-4CDD-8D60-B66C4CA9B1F9Q38958606-019FD3DC-B600-4EA7-B26E-2C224B8E48EDQ38959114-6344E881-F9F4-4D79-B099-56C093DAFA47Q38965204-423BC187-B31C-4C7E-BAE0-BC4595CDB95BQ39004950-428CCF2D-1D3C-45DD-B4C6-B0F0B514978EQ39025924-FB895B4E-E529-4DA1-90A0-38BF3B3721B4Q39099572-3D7BE4C3-BD49-4E76-A4C2-78A3F56956B2Q39261789-8C74A70E-438C-488A-8818-6D121F532DA6Q40277752-F962DD4D-E11A-4DEE-A2D5-15A817010643Q40646396-5A49D542-0D95-46AA-B9A5-1E8407725FA3Q41623532-3D66A708-634E-49A8-AC0E-BF46AC70D6BD
P2860
AP4 is a mediator of epithelial-mesenchymal transition and metastasis in colorectal cancer
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
AP4 is a mediator of epithelia ...... etastasis in colorectal cancer
@en
type
label
AP4 is a mediator of epithelia ...... etastasis in colorectal cancer
@en
prefLabel
AP4 is a mediator of epithelia ...... etastasis in colorectal cancer
@en
P2093
P2860
P50
P356
P1476
AP4 is a mediator of epithelia ...... etastasis in colorectal cancer
@en
P2093
Christian Berens
David Horst
Heiko Hermeking
Jens Neumann
Peter Jung
Rene Jackstadt
Simone Röh
Thomas Kirchner
P2860
P304
P356
10.1084/JEM.20120812
P407
P577
2013-06-10T00:00:00Z